New research has uncovered a process in the brain that could pave the way for future treatments of neurodevelopmental and ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

Scientists from Yale University have revealed how the brain protects itself from the toxic effects of calcium, which may hold ...

Dementia is the term that most commonly comes to mind when one thinks of Alzheimer's, yet there is one more form of cognitive ...

People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk ...

Certain amounts of hydrogen sulfide can help protect aging brains from Alzheimer’s disease, according to a 2021 study ...

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate ...

Citi Annual Global Healthcare Conference 2025 December 3, 2025 3:15 PM ESTCompany ParticipantsMichael Davidson ...

Kidney health may not raise dementia risk, but it can shift how fast dementia symptoms appear in those already vulnerable.

People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk ...